These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12836517)

  • 1. [Limits and weaknesses of intermittent treatment in malaria prevention].
    Chippaux JP; Le Hesran JY; Cot M; Massougbodji A
    Bull Soc Pathol Exot; 2003 May; 96(2):75-6. PubMed ID: 12836517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
    Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
    J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose sulfadoxine-pyrimethamine in intermittent preventive treatment of malaria.
    Gosling RD; Schellenberg DM; Chandramohan D
    J Infect Dis; 2006 Jun; 193(11):1609-10; author reply 1610-1. PubMed ID: 16652293
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.
    Bakyaita N; Dorsey G; Yeka A; Banek K; Staedke SG; Kamya MR; Talisuna A; Kironde F; Nsobya S; Kilian A; Reingold A; Rosenthal PJ; Wabwire-Mangen F
    Am J Trop Med Hyg; 2005 May; 72(5):573-80. PubMed ID: 15891132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru.
    Marquiño W; Ylquimiche L; Hermenegildo Y; Palacios AM; Falconí E; Cabezas C; Arróspide N; Gutierrez S; Ruebush TK
    Am J Trop Med Hyg; 2005 May; 72(5):568-72. PubMed ID: 15891131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent preventive antimalarial treatment in infancy.
    WHO IPTi Technical Expert Group
    Lancet; 2008 Oct; 372(9647):1383-4. PubMed ID: 18940461
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.
    Macete E; Aide P; Aponte JJ; Sanz S; Mandomando I; Espasa M; Sigauque B; Dobaño C; Mabunda S; DgeDge M; Alonso P; Menendez C
    J Infect Dis; 2006 Aug; 194(3):276-85. PubMed ID: 16826474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ocular manifestations and sequelae of Lyell syndrome caused by sulfadoxine-pyrimethamine in Cameroon].
    Moussala M; Binam F; Nkam M; Kouda Zeh A; Bengono G
    J Fr Ophtalmol; 1998 Jan; 21(1):72-7. PubMed ID: 9834901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfadoxine-pyrimethamine as an anti-malaria preventative in donated blood.
    Boctor F
    Am J Trop Med Hyg; 2006 May; 74(5):705; author reply 705. PubMed ID: 16687665
    [No Abstract]   [Full Text] [Related]  

  • 12. Surveillance for adverse drug reactions to combination antimalarial therapy with sulfadoxine-pyrimethamine plus artesunate in Peru.
    Cairo J; Durand S; Marquiño W; Cabezas C; Lachira A; Quintana F; Vegas W; Ruebush TK; Utz G; Bacon DJ
    Am J Trop Med Hyg; 2008 Jul; 79(1):42-4. PubMed ID: 18606762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and prospects of combination therapy as a strategy for delaying antimalarial drug resistance.
    Alexander ND
    P N G Med J; 2001; 44(1-2):1-5. PubMed ID: 12418672
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with noncomplicated malaria.
    Menard D; Madji N; Manirakiza A; Djalle D; Koula MR; Talarmin A
    Am J Trop Med Hyg; 2005 May; 72(5):581-5. PubMed ID: 15940847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent preventive therapy with sulfadoxine-pyrimethamine during pregnancy: seeking information on optimal dosing frequency.
    Ter Kuile FO; Steketee RW
    J Infect Dis; 2007 Dec; 196(11):1574-6. PubMed ID: 18008239
    [No Abstract]   [Full Text] [Related]  

  • 16. Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Falade CO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2004 May; 9(5):606-14. PubMed ID: 15117306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of combined chloroquine and sulfadoxine-pyrimethamine in uncomplicated Plasmodium falciparum malaria in Bangladesh.
    Rahman M; Rahman R; Bangali M; Das S; Talukder MR; Ringwald P
    Trans R Soc Trop Med Hyg; 2004 Jul; 98(7):438-41. PubMed ID: 15138082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine.
    Marks F; von Kalckreuth V; Kobbe R; Adjei S; Adjei O; Horstmann RD; Meyer CG; May J
    J Infect Dis; 2005 Dec; 192(11):1962-5. PubMed ID: 16267768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
    Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
    Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
    Mayor A; Serra-Casas E; Sanz S; Aponte JJ; Macete E; Mandomando I; Puyol L; Berzosa P; Dobaño C; Aide P; Sacarlal J; Benito A; Alonso P; Menéndez C
    J Infect Dis; 2008 Jun; 197(12):1737-42. PubMed ID: 18419347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.